Dry powder inhaler
A dry powder inhaler 1 comprising a container 7 for storing a powdered medicament, a deagglomerator 25 with a vortex chamber 26 located at an end of an inhalation channel 8 which is connected to a mouthpiece 4, and a metering device 14 comprising a shuttle 16 having a dosing recess 15. The shuttle 1...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Stuart Robert Abercrombie Marco Di Castri Donal Joseph Taylor |
| description | A dry powder inhaler 1 comprising a container 7 for storing a powdered medicament, a deagglomerator 25 with a vortex chamber 26 located at an end of an inhalation channel 8 which is connected to a mouthpiece 4, and a metering device 14 comprising a shuttle 16 having a dosing recess 15. The shuttle 16 is movable between a filling position, in which the dosing recess 15 is in alignment with an opening 17 of the container 7 (Fig 2A), and an inhalation position, in which the dosing recess 15 is in alignment with the vortex chamber 26 (Fig 2C). The opening 17 of the container 7 is elongated along a major axis (Y-Y, Fig 9) and the dosing recess (15) is elongated along a main axis (X-X, Fig 9). When the shuttle 16 is in the filling position, an edge (27, Fig 9) of the opening 17 of the container 7 encloses the dosing recess 15. Also disclosed is a pharmaceutical composition, in the form of a powdered medicament suitable for administering using such an inhaler, the composition preferably comprising one or more phosphodiesterase-4 (PDE-4) inhibitors; preferably tanimilast. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_GB2621707A9</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>GB2621707A9</sourcerecordid><originalsourceid>FETCH-epo_espacenet_GB2621707A93</originalsourceid><addsrcrecordid>eNrjZBByKapUKMgvT0ktUsjMy0jMSS3iYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXx7k5GZkaG5gbmjpbGRCgBAK9nH24</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Dry powder inhaler</title><source>esp@cenet</source><creator>Stuart Robert Abercrombie ; Marco Di Castri ; Donal Joseph Taylor</creator><creatorcontrib>Stuart Robert Abercrombie ; Marco Di Castri ; Donal Joseph Taylor</creatorcontrib><description>A dry powder inhaler 1 comprising a container 7 for storing a powdered medicament, a deagglomerator 25 with a vortex chamber 26 located at an end of an inhalation channel 8 which is connected to a mouthpiece 4, and a metering device 14 comprising a shuttle 16 having a dosing recess 15. The shuttle 16 is movable between a filling position, in which the dosing recess 15 is in alignment with an opening 17 of the container 7 (Fig 2A), and an inhalation position, in which the dosing recess 15 is in alignment with the vortex chamber 26 (Fig 2C). The opening 17 of the container 7 is elongated along a major axis (Y-Y, Fig 9) and the dosing recess (15) is elongated along a main axis (X-X, Fig 9). When the shuttle 16 is in the filling position, an edge (27, Fig 9) of the opening 17 of the container 7 encloses the dosing recess 15. Also disclosed is a pharmaceutical composition, in the form of a powdered medicament suitable for administering using such an inhaler, the composition preferably comprising one or more phosphodiesterase-4 (PDE-4) inhibitors; preferably tanimilast.</description><language>eng</language><subject>DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROMTHE BODY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20241002&DB=EPODOC&CC=GB&NR=2621707A9$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25569,76552</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20241002&DB=EPODOC&CC=GB&NR=2621707A9$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Stuart Robert Abercrombie</creatorcontrib><creatorcontrib>Marco Di Castri</creatorcontrib><creatorcontrib>Donal Joseph Taylor</creatorcontrib><title>Dry powder inhaler</title><description>A dry powder inhaler 1 comprising a container 7 for storing a powdered medicament, a deagglomerator 25 with a vortex chamber 26 located at an end of an inhalation channel 8 which is connected to a mouthpiece 4, and a metering device 14 comprising a shuttle 16 having a dosing recess 15. The shuttle 16 is movable between a filling position, in which the dosing recess 15 is in alignment with an opening 17 of the container 7 (Fig 2A), and an inhalation position, in which the dosing recess 15 is in alignment with the vortex chamber 26 (Fig 2C). The opening 17 of the container 7 is elongated along a major axis (Y-Y, Fig 9) and the dosing recess (15) is elongated along a main axis (X-X, Fig 9). When the shuttle 16 is in the filling position, an edge (27, Fig 9) of the opening 17 of the container 7 encloses the dosing recess 15. Also disclosed is a pharmaceutical composition, in the form of a powdered medicament suitable for administering using such an inhaler, the composition preferably comprising one or more phosphodiesterase-4 (PDE-4) inhibitors; preferably tanimilast.</description><subject>DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY</subject><subject>DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR</subject><subject>DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROMTHE BODY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZBByKapUKMgvT0ktUsjMy0jMSS3iYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXx7k5GZkaG5gbmjpbGRCgBAK9nH24</recordid><startdate>20241002</startdate><enddate>20241002</enddate><creator>Stuart Robert Abercrombie</creator><creator>Marco Di Castri</creator><creator>Donal Joseph Taylor</creator><scope>EVB</scope></search><sort><creationdate>20241002</creationdate><title>Dry powder inhaler</title><author>Stuart Robert Abercrombie ; Marco Di Castri ; Donal Joseph Taylor</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_GB2621707A93</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2024</creationdate><topic>DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY</topic><topic>DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR</topic><topic>DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROMTHE BODY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>Stuart Robert Abercrombie</creatorcontrib><creatorcontrib>Marco Di Castri</creatorcontrib><creatorcontrib>Donal Joseph Taylor</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Stuart Robert Abercrombie</au><au>Marco Di Castri</au><au>Donal Joseph Taylor</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Dry powder inhaler</title><date>2024-10-02</date><risdate>2024</risdate><abstract>A dry powder inhaler 1 comprising a container 7 for storing a powdered medicament, a deagglomerator 25 with a vortex chamber 26 located at an end of an inhalation channel 8 which is connected to a mouthpiece 4, and a metering device 14 comprising a shuttle 16 having a dosing recess 15. The shuttle 16 is movable between a filling position, in which the dosing recess 15 is in alignment with an opening 17 of the container 7 (Fig 2A), and an inhalation position, in which the dosing recess 15 is in alignment with the vortex chamber 26 (Fig 2C). The opening 17 of the container 7 is elongated along a major axis (Y-Y, Fig 9) and the dosing recess (15) is elongated along a main axis (X-X, Fig 9). When the shuttle 16 is in the filling position, an edge (27, Fig 9) of the opening 17 of the container 7 encloses the dosing recess 15. Also disclosed is a pharmaceutical composition, in the form of a powdered medicament suitable for administering using such an inhaler, the composition preferably comprising one or more phosphodiesterase-4 (PDE-4) inhibitors; preferably tanimilast.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_GB2621707A9 |
| source | esp@cenet |
| subjects | DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROMTHE BODY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Dry powder inhaler |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-16T07%3A15%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Stuart%20Robert%20Abercrombie&rft.date=2024-10-02&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EGB2621707A9%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |